Willem Joost Lesterhuis
7PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 17, 2024
Exploiting temporal aspects of cancer immunotherapy.Rachael M Zemek, Valsamo Anagnostou, Inês Pires da Silva
|Aug 19, 2022
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice.Rachael M Zemek, Wee Loong Chin, Vanessa S Fear
|Jun 01, 2021
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery.Jeroen H A Creemers, W Joost Lesterhuis, Niven Mehra
|Apr 03, 2020
Bilateral murine tumor models for characterizing the response to immune checkpoint blockade.Rachael M Zemek, Vanessa S Fear, Cath Forbes
|Jan 26, 2020
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.Steve Boudewijns, Martine Bloemendal, Nienke de Haas
|Oct 25, 2019
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment.Wayne J Aston, Danika E Hope, Alistair M Cook
Pageof 2
Frequent Collaborators
4 joint publications
Rachael M Zemek
4 joint publications
Anna K Nowak
3 joint publications
Timo Lassmann
3 joint publications
Richard A Lake
2 joint publications
I Jolanda M de Vries
2 joint publications
Thomas H Casey
2 joint publications
Louis Boon
2 joint publications
Carl G Figdor
2 joint publications
Winald R Gerritsen
1 joint publications
Sarah J Dart
